These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 29749438)
1. Oct4 suppresses IR‑induced premature senescence in breast cancer cells through STAT3- and NF‑κB-mediated IL‑24 production. Kim JY; Kim JC; Lee JY; Park MJ Int J Oncol; 2018 Jul; 53(1):47-58. PubMed ID: 29749438 [TBL] [Abstract][Full Text] [Related]
2. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066. Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424 [TBL] [Abstract][Full Text] [Related]
4. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor. Beltran AS; Rivenbark AG; Richardson BT; Yuan X; Quian H; Hunt JP; Zimmerman E; Graves LM; Blancafort P Breast Cancer Res; 2011 Sep; 13(5):R94. PubMed ID: 21952072 [TBL] [Abstract][Full Text] [Related]
5. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer. Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA ES1 controls the proliferation of breast cancer cells by regulating the Oct4/Sox2/miR-302 axis. Keshavarz M; Asadi MH FEBS J; 2019 Jul; 286(13):2611-2623. PubMed ID: 30927330 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of EID3 sensitizes breast cancer cells to ionizing radiation-induced cellular senescence. Wang Y; Wang Y; Liu S; Liu Y; Xu H; Liang J; Zhu J; Zhang G; Su W; Dong W; Guo Q Biomed Pharmacother; 2018 Nov; 107():606-614. PubMed ID: 30114644 [TBL] [Abstract][Full Text] [Related]
8. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity. Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536 [TBL] [Abstract][Full Text] [Related]
9. Betavulgarin Isolated from Sugar Beet ( Liu R; Choi HS; Zhen X; Kim SL; Kim JH; Ko YC; Yun BS; Lee DS Molecules; 2020 Jun; 25(13):. PubMed ID: 32630026 [TBL] [Abstract][Full Text] [Related]
10. Reprogramming Factors Remodel Melanoma Cell Phenotype by Changing Stat3 Expression. Wang Y; Mou Y; Zhang H; Wang X; Li R; Cheng Z; Liu X Int J Med Sci; 2017; 14(13):1402-1409. PubMed ID: 29200954 [TBL] [Abstract][Full Text] [Related]
11. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance. Gwak JM; Kim M; Kim HJ; Jang MH; Park SY Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735 [TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551 [TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways. Lin C; Wang L; Wang H; Yang L; Guo H; Wang X J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622 [TBL] [Abstract][Full Text] [Related]
14. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771 [TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells. Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986 [TBL] [Abstract][Full Text] [Related]
16. High-dose Ionizing Radiation Regulates Gene Expression Changes in the MCF7 Breast Cancer Cell Line. Bravatà V; Minafra L; Russo G; Forte GI; Cammarata FP; Ripamonti M; Casarino C; Augello G; Costantini F; Barbieri G; Messa C; Gilardi MC Anticancer Res; 2015 May; 35(5):2577-91. PubMed ID: 25964533 [TBL] [Abstract][Full Text] [Related]
17. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells. Kang Y; Park MA; Heo SW; Park SY; Kang KW; Park PH; Kim JA Biochim Biophys Acta; 2013 Mar; 1830(3):2638-48. PubMed ID: 23246576 [TBL] [Abstract][Full Text] [Related]
18. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2. Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964 [TBL] [Abstract][Full Text] [Related]
19. STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers. Kim JS; Kim HA; Seong MK; Seol H; Oh JS; Kim EK; Chang JW; Hwang SG; Noh WC Oncotarget; 2016 Feb; 7(6):7055-65. PubMed ID: 26755645 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes. Seo S; Jeon HY; Kim H DNA Cell Biol; 2017 Nov; 36(11):1000-1009. PubMed ID: 28933914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]